Gastrointestinal Cancer

4:05
PLATO and immunotherapy trials in anal cancer
David Sebag-Montefiore
2:30
ClarIDHy: updates and initial findings for ivosidenib in CCA
Ghassan Abou-Alfa
1:32
Ghassan Abou-Alfa talks pemigatinib and cabozantinib
Ghassan Abou-Alfa
3:17
Optimism for apatinib in gastric cancer
Steven Norton
4:00
Current challenges and key developments in CRC
Kai-Keen Shiu
3:09
Precision medicine in gastrointestinal cancers: promise and pitfalls
Russell Petty
4:31
Colorectal cancer subtyping using a histology based approach
Joanne Edwards
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
1:56
ISOPP 2019 reviews ESMO: data highlights
Dharmisha Chauhan
3:45
Molecular target therapy in pancreatic and liver cancer
Hani Babiker
2:54
ILLUMINATE 101: Updates and implications on colorectal cancer
Hani Babiker
3:46
CheckMate 459: updates on nivolumab monotherapy for HCC
Thomas Yau
0:56
MOUNTAINEER results: trastuzumab and tucatinib for HER2+ mCRC
John Strickler
2:31
IDEA-FRANCE: ctDNA as a predictive value for adjuvant treatment duration
Thierry André
1:15
John Strickler: ESMO 2019 Highlights
John Strickler
2:20
AVANT: bevacizumab + oxaliplatin-based chemo for colon cancer
Thierry André
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals